Quotient Wealth Partners LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,400 shares of the healthcare conglomerate's stock after selling 764 shares during the quarter. Quotient Wealth Partners LLC's holdings in UnitedHealth Group were worth $749,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of the business. Koshinski Asset Management Inc. lifted its stake in shares of UnitedHealth Group by 16.7% in the 2nd quarter. Koshinski Asset Management Inc. now owns 10,825 shares of the healthcare conglomerate's stock valued at $3,377,000 after purchasing an additional 1,546 shares during the last quarter. Citizens Business Bank lifted its stake in shares of UnitedHealth Group by 0.9% in the 2nd quarter. Citizens Business Bank now owns 8,368 shares of the healthcare conglomerate's stock valued at $2,611,000 after purchasing an additional 75 shares during the last quarter. Hoese & Co LLP lifted its stake in shares of UnitedHealth Group by 566.7% in the 2nd quarter. Hoese & Co LLP now owns 1,000 shares of the healthcare conglomerate's stock valued at $312,000 after purchasing an additional 850 shares during the last quarter. Ariston Services Group lifted its stake in shares of UnitedHealth Group by 13.6% in the 2nd quarter. Ariston Services Group now owns 953 shares of the healthcare conglomerate's stock valued at $297,000 after purchasing an additional 114 shares during the last quarter. Finally, Huntleigh Advisors Inc. lifted its stake in shares of UnitedHealth Group by 331.5% in the 2nd quarter. Huntleigh Advisors Inc. now owns 8,700 shares of the healthcare conglomerate's stock valued at $2,714,000 after purchasing an additional 6,684 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently commented on UNH. Zacks Research raised UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research note on Monday, October 6th. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Jefferies Financial Group increased their target price on UnitedHealth Group from $317.00 to $409.00 and gave the stock a "buy" rating in a research note on Friday. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. Finally, Robert W. Baird reissued an "underperform" rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $385.13.
View Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Price Performance
UNH stock opened at $356.53 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $322.90 billion, a P/E ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The business's 50-day moving average is $329.38 and its two-hundred day moving average is $344.86. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.